These iron-positive macrophages (iTAMs) are hallmarked by low expression of the iron exporter ferroportin and positivity for CD86, CD163, and HMOX1 as well as a pro-inflammatory phenotype with the ability to kill tumor cells. The gene discussed is CD86; the disease is neoplasm.